Haleon plc
HLN
Clasificación en acciones
#13711
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Precio por acción
$5.01
Última sincronización: 2026-10-21
Capitalización bursátil
$440.22M
Cambio (1 día)
-2.22%
Cambio (1 año)
6.27%
País
GB
Comercio Haleon plc (HLN)
Categoría
Healthcare
Historial del precio de la acción de Haleon plc (HLN)
Precio más alto de cierre: $4.68 el 2026-10-01
Precio más bajo de cierre: $3.48 el 2022-07-01
Precio más bajo de cierre: $3.48 el 2022-07-01
Historial del precio de la acción de Haleon plc desde 2022 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | -0.76% |
| 2025 | 2.79% |
| 2024 | 16.19% |
| 2023 | 13.23% |
| 2022 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $18.42 | -4.08% |
IN
|
